Medical Equipment

Automated Compounding Devices Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

March 10, 2026March 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Automated Compounding Devices Market By 2030 Starting From Its 2026 Size?

The automated compounding devices market has experienced robust expansion in recent years. This market is projected to grow from $2.51 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Key drivers for this historical growth include an escalating workload in hospital pharmacies, a rising demand for sterile IV preparation, the early adoption of TPN compounding automation, hospital initiatives aimed at reducing compounding errors, and the expansion of inpatient medication therapy volumes.

The automated compounding devices market is expected to experience robust growth in the coming years, with its size projected to reach $3.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This expansion during the forecast period is fueled by a growing emphasis on medication safety compliance, increasing investments in automated pharmacy technology, the rising outsourcing of sterile compounding services, the expansion of oncology and critical care drug compounding, and the greater integration of digital workflow and reporting systems. Key trends anticipated include the increasing adoption of automated compounding devices to reduce errors in manual medication preparation within hospital and pharmacy environments, a rising demand for high-precision compounding of IV formulations, oncology drugs, and TPN solutions, a growing transition toward centralized and large-volume sterile compounding facilities in healthcare systems, the expanding use of automated workflow validation and barcode-based verification in compounding processes, and an increasing preference for compact, modular, and upgradeable automated compounding platforms for pharmacy operations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

Which Market Drivers Are Supporting The Expansion Of The Automated Compounding Devices Market?

The automated compounding devices market is expected to grow, driven by the increasing prevalence of personalized medicines. This medical approach tailors healthcare decisions and treatments to the unique characteristics of individual patients, a trend fueled by improved understanding of genetics, patient-specific data, and robust regulatory support. Automated compounding devices (ACDs) are essential in personalized medicine, enabling the precise preparation of custom medication formulations by automating the process of combining various pharmaceutical ingredients in specific proportions to create tailored treatments. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant rise from six in 2022. This expanding landscape of personalized medicines is therefore a key factor driving the growth of the automated compounding devices market.

Which Segment Categories Define The Automated Compounding Devices Market?

The automated compounding devices market covered in this report is segmented –

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software

2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems

3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems

4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)

2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

What Major Market Trends Are Driving Changes In The Automated Compounding Devices Market?

Leading companies in the automated compounding devices market are focusing on AI-powered robotic compounding, specifically AI-enabled IV compounding platform systems that utilize artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with high precision, real-time quality checks, and continuous oversight. For instance, in August 2025, Omnicell, a US-based health-technology company, launched an AI-enhanced upgrade for its IV compounding system, designed to bolster safety and accuracy in medication preparation. This updated system integrates advanced AI-based quality-assurance tools that continuously monitor compounding activities, automatically detecting and flagging any deviations from expected procedures. By introducing this level of automated oversight, Omnicell aims to reduce human error, improve workflow efficiency, and support higher standards of medication quality in pharmacy operations.

Who Are The Top Companies Competing In The Automated Compounding Devices Market?

Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc

Read the full automated compounding devices market report here:

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

How Is The Automated Compounding Devices Market Distributed Across Key Geographic Regions?

North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Automated Compounding Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp

Browse Through More Reports Similar to the Global Automated Compounding Devices Market 2026, By The Business Research Company

Plastic Compounding Market Report 2026

https://www.thebusinessresearchcompany.com/report/plastic-compounding-global-market-report

Compound Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/compound-management-global-market-report

Electronic Products Market 2026

https://www.thebusinessresearchcompany.com/report/electronic-products-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795